Homepage Archives - Geneseeq Technology Inc. | A Precision Oncology Company

June 24, 2021

Geneseeq works with HUTCHMED and AstraZeneca in MET inhibitor approval for lung cancer patients in China

June 17, 2021

Geneseeq Joins Integrated DNA Technologies (IDT) Align Program

May 26, 2021

Geneseeq Presenting Data at the American Society of Clinical Oncology Annual Meeting 2021

May 18, 2021

Geneseeq study shows ctDNA evaluation in early postoperative phase predicts risk of recurrence in colorectal cancer

April 27, 2021

Geneseeq and AstraZeneca Collaborate to Build Guangzhou Bio-Diagnostics Innovation Center

April 9, 2021

Geneseeq to Present at American Association for Cancer Research Annual Meeting 2021

March 25, 2021

Genomic Study Uncovers New Biomarkers for the Efficacy of Immunotherapy in Nasopharyngeal Carcinoma (NPC) Patients

March 16, 2021

Geneseeq Collaborates with Illumina to Develop and Commercialize Comprehensive Cancer In-vitro Diagnostic NGS kit

January 25, 2021

Geneseeq and Collaborators to Present New Clinical Research Data during the 2020 IASLC World Conference on Lung Cancer in Singapore

May 13, 2019

New biomarkers to predict patients’ clinical outcomes to ICI therapy in lung cancer

by Thomas Fischer